Blog
CRISPR activation and interference screens decode stimulation responses in primary human T cells – Science
CRISPR genome editing has served as a powerful tool to
CRISPR genome editing has served as a powerful tool to
Clinicians treating patients with CAR T cells have become adept
The adoptive transfer of T lymphocytes reprogrammed to target tumour
CAR-M is a therapy that begins with the isolation of
For 17 years, Thomas Blankenstein has been working on his
A group of researchers set out to characterize the genotypic
CAR-T cell therapy, which received FDA approval in 2017, are
Solid tumors are surrounded by an immunosuppressive tumor microenvironment. Therefore,
The CAR T-cell therapy idecabtagene vicleucel (ide-cel; Abecma) continues to